About the Congenital Hyperinsulinism Center
The Congenital Hyperinsulinism Center at Children's Hospital of Philadelphia (CHOP) offers evaluation, diagnosis, treatment and follow-up care for children with hyperinsulinism (HI). Since most children’s hospitals only encounter one or two cases per year, it is important that children with this rare disease receive medical care from an experienced team. Founded in 1998, the Congenital Hyperinsulinism Center has evaluated and treated more than 1,600 patients — making it the largest program of its kind in the world.
Our team of experts include pediatric endocrinologists, surgeons, radiologists, pathologists, anesthesiologists, advanced practice nurses, nurses, social workers, genetic counselors, psychologists, researchers, speech and feeding therapists, and dieticians — all working together to provide specialized, patient-centered and seamless care for children with congenital HI and their families.
Our Congenital Hyperinsulinism Center was designated a Frontier Program by CHOP in 2019. Frontier Programs are unique, cutting-edge programs that forge important new discoveries, deliver novel therapies and help even more children thrive. In 2021, Congenital Hyperinsulinism International named our center a Hyperinsulinism Center of Excellence.
